UY30416A1 - Inhibidores de proteasa de hiv de 2-(amino-sustituido)-benzotiazol sulfonamida - Google Patents
Inhibidores de proteasa de hiv de 2-(amino-sustituido)-benzotiazol sulfonamidaInfo
- Publication number
- UY30416A1 UY30416A1 UY30416A UY30416A UY30416A1 UY 30416 A1 UY30416 A1 UY 30416A1 UY 30416 A UY30416 A UY 30416A UY 30416 A UY30416 A UY 30416A UY 30416 A1 UY30416 A1 UY 30416A1
- Authority
- UY
- Uruguay
- Prior art keywords
- amino
- substituted
- protease inhibitors
- hiv protease
- benzotiazol
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 3
- 239000004030 hiv protease inhibitor Substances 0.000 title abstract 2
- 150000003456 sulfonamides Chemical class 0.000 title 1
- 125000003277 amino group Chemical group 0.000 abstract 2
- 229940124522 antiretrovirals Drugs 0.000 abstract 1
- 239000003903 antiretrovirus agent Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06116003 | 2006-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY30416A1 true UY30416A1 (es) | 2008-01-31 |
Family
ID=37596252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY30416A UY30416A1 (es) | 2006-06-23 | 2007-06-15 | Inhibidores de proteasa de hiv de 2-(amino-sustituido)-benzotiazol sulfonamida |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8202887B2 (enExample) |
| EP (1) | EP2035432B1 (enExample) |
| JP (1) | JP5232776B2 (enExample) |
| KR (1) | KR101419320B1 (enExample) |
| CN (1) | CN101479275B (enExample) |
| AP (1) | AP2069A (enExample) |
| AR (1) | AR061619A1 (enExample) |
| AT (1) | ATE544769T1 (enExample) |
| AU (1) | AU2007262943B2 (enExample) |
| BR (1) | BRPI0713487B1 (enExample) |
| CA (1) | CA2653233C (enExample) |
| CL (1) | CL2007001826A1 (enExample) |
| CY (1) | CY1112971T1 (enExample) |
| DK (1) | DK2035432T3 (enExample) |
| EA (1) | EA016387B1 (enExample) |
| ES (1) | ES2381129T3 (enExample) |
| IL (1) | IL195381A (enExample) |
| JO (1) | JO2841B1 (enExample) |
| MX (1) | MX2009000160A (enExample) |
| MY (1) | MY146805A (enExample) |
| NZ (1) | NZ573286A (enExample) |
| PE (1) | PE20080342A1 (enExample) |
| PL (1) | PL2035432T3 (enExample) |
| PT (1) | PT2035432E (enExample) |
| SI (1) | SI2035432T1 (enExample) |
| TW (1) | TWI415851B (enExample) |
| UA (1) | UA96445C2 (enExample) |
| UY (1) | UY30416A1 (enExample) |
| WO (1) | WO2007147884A1 (enExample) |
| ZA (1) | ZA200810350B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3090B1 (ar) * | 2009-12-11 | 2017-03-15 | Janssen Sciences Ireland Uc | 5- امينو-4- هيدروكسي-بنتويل اميدات |
| EP2588455B1 (en) | 2010-07-02 | 2018-04-04 | Gilead Sciences, Inc. | 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| MX2012015097A (es) | 2010-07-02 | 2013-05-28 | Gilead Sciences Inc | Derivados de acido naft-2-ilacetico para tratar sida. |
| US9024038B2 (en) | 2010-12-27 | 2015-05-05 | Purdue Research Foundation | Compunds and methods for treating HIV |
| UA111841C2 (uk) * | 2011-04-21 | 2016-06-24 | Гіліад Сайєнсіз, Інк. | Сполуки бензотіазолу та їх фармацевтичне застосування |
| US9376392B2 (en) | 2012-01-04 | 2016-06-28 | Gilead Sciences, Inc. | 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS |
| US9284323B2 (en) | 2012-01-04 | 2016-03-15 | Gilead Sciences, Inc. | Naphthalene acetic acid derivatives against HIV infection |
| UY34750A (es) | 2012-04-20 | 2013-11-29 | Gilead Sciences Inc | ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?. |
| US20230218644A1 (en) | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
| US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7659404B2 (en) * | 2001-02-14 | 2010-02-09 | Tibotec Pharmaceuticals Ltd. | Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| TWI286476B (en) * | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
| CN1671380B (zh) * | 2002-08-02 | 2010-05-26 | 泰博特克药品有限公司 | 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂 |
| US20080234288A1 (en) * | 2003-09-30 | 2008-09-25 | Kenneth Alan Simmen | Hcv Inhibiting Sulfonamides |
-
2007
- 2007-06-04 JO JO2007212A patent/JO2841B1/en active
- 2007-06-15 UY UY30416A patent/UY30416A1/es not_active Application Discontinuation
- 2007-06-21 CL CL2007001826A patent/CL2007001826A1/es unknown
- 2007-06-22 ES ES07765554T patent/ES2381129T3/es active Active
- 2007-06-22 NZ NZ573286A patent/NZ573286A/en not_active IP Right Cessation
- 2007-06-22 AR ARP070102776A patent/AR061619A1/es active IP Right Grant
- 2007-06-22 EA EA200970052A patent/EA016387B1/ru not_active IP Right Cessation
- 2007-06-22 AP AP2008004679A patent/AP2069A/en active
- 2007-06-22 AU AU2007262943A patent/AU2007262943B2/en not_active Ceased
- 2007-06-22 PT PT07765554T patent/PT2035432E/pt unknown
- 2007-06-22 UA UAA200813950A patent/UA96445C2/ru unknown
- 2007-06-22 SI SI200730904T patent/SI2035432T1/sl unknown
- 2007-06-22 CN CN2007800236807A patent/CN101479275B/zh active Active
- 2007-06-22 KR KR1020097000754A patent/KR101419320B1/ko not_active Expired - Fee Related
- 2007-06-22 CA CA2653233A patent/CA2653233C/en active Active
- 2007-06-22 EP EP07765554A patent/EP2035432B1/en active Active
- 2007-06-22 TW TW096122406A patent/TWI415851B/zh not_active IP Right Cessation
- 2007-06-22 JP JP2009515891A patent/JP5232776B2/ja not_active Expired - Fee Related
- 2007-06-22 DK DK07765554.6T patent/DK2035432T3/da active
- 2007-06-22 BR BRPI0713487-8A patent/BRPI0713487B1/pt not_active IP Right Cessation
- 2007-06-22 US US12/304,990 patent/US8202887B2/en not_active Expired - Fee Related
- 2007-06-22 MX MX2009000160A patent/MX2009000160A/es active IP Right Grant
- 2007-06-22 MY MYPI20085209A patent/MY146805A/en unknown
- 2007-06-22 PL PL07765554T patent/PL2035432T3/pl unknown
- 2007-06-22 WO PCT/EP2007/056235 patent/WO2007147884A1/en not_active Ceased
- 2007-06-22 AT AT07765554T patent/ATE544769T1/de active
- 2007-06-22 PE PE2007000802A patent/PE20080342A1/es active IP Right Grant
-
2008
- 2008-11-19 IL IL195381A patent/IL195381A/en active IP Right Grant
- 2008-12-05 ZA ZA200810350A patent/ZA200810350B/xx unknown
-
2012
- 2012-05-08 CY CY20121100429T patent/CY1112971T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY30416A1 (es) | Inhibidores de proteasa de hiv de 2-(amino-sustituido)-benzotiazol sulfonamida | |
| UY31806A (es) | Compuestos de tiazole y oxazole de sulfonamida de benceno | |
| CR11618A (es) | Inhibidores macrocíclicos de serina proteasa | |
| CL2018002703A1 (es) | Agentes de iarn, composiciones y métodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr). (divisional solicitud 201401291) | |
| CL2008001756A1 (es) | Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac) | |
| CL2008003405A1 (es) | Compuestos derivados de tienopiridina, inhibidores de la enzima integrasa del vih; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion por vih. | |
| NI201000055A (es) | 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa. | |
| CL2007001391A1 (es) | Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico | |
| CL2007001392A1 (es) | Compuestos derivados de quinolina o benzopirano inhibidores de la replicacion del hiv; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una infeccion por vih | |
| BR112019010622A2 (pt) | composição, métodos para preparação da composição, para remover manchas e para limpeza, microcápsula, e, uso de pentano-1,2-diol. | |
| CL2010001428A1 (es) | Compuestos derivados de amidas y tioamidas heteroaromaticas; agente que contiene al menos uno de dichos compuestos; procedimiento para combatir parasitos; y uso de dichos compuestos. | |
| UY30511A1 (es) | Agonistas de ep2 | |
| DOP2011000076A (es) | Derivados de heteroaril amidas y su uso como activadores de glucoquinasa | |
| UY30610A1 (es) | Moduladores de mglur5 | |
| ECSP088288A (es) | DERIVADOS DE 7-(2-AMINO-1-HIDROXI-ETIL)-4-HIDROXIBENZOTIAZOL-2(3H)-ONA COMO AGONISTAS DE LOS ADRENOCEPTORES ß2 | |
| CR8824A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
| HN2009000566A (es) | Nuevos derivados de diosmetina, su procedimiento de prearacion y las composiciones farmaceuticas que lo contienen. | |
| HN2008001521A (es) | Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica | |
| CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
| CL2011002258A1 (es) | Compuestos derivados heterociclicos fusionados; composicion farmaceutica que los comprende; y uso de los compuestos para tratar vih. | |
| CR10280A (es) | Anticuerpos de la efgl7 y metodos de uso | |
| CL2008002084A1 (es) | Compuestos derivados de bencensulfonil cromano, tiocromano, tetrahidronaftaleno, inhibidores de la gamma secretasa; composicion farmaceutica que lo comprende; y su uso en la preparacion de medicamentos utiles para tratar enfermedades neurodegenerativas | |
| UY29648A1 (es) | Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
| BRPI0618654A8 (pt) | variante de zimogênio/protease de fator x/fator xa, ácido nucléico, composição farmacêutica que os contém, vetor, bem como uso dos mesmos | |
| UY30087A1 (es) | Piperazinas y piperidinas como potenciadoras de mglur5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RDES | Application refused |
Effective date: 20191011 |